Correspondence 0001193125-23-252379 from ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC.
Date: Oct. 6, 2023 · CIK: 0001434647 · Accession: 0001193125-23-252379
AI Filing Summary & Sentiment
File numbers found in text: 333-274758
Letter
VIA EDGAR Securities and Exchange Commission Attention: Joshua Gorsky Registration Statement on Form S-4 Filed September 28, 2023 (Commission File No. 333-274758)
Re: Zevra Therapeutics, Inc.
Dear Sir or Madam:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Zevra Therapeutics, Inc. (the “Company”) hereby requests that the Registration Statement referred to above be declared effective on Tuesday, October 10, 2023 at 4:30 p.m. E.T. or as soon thereafter as shall be practicable.
Very truly yours,
/s/ R. LaDuane
Clifton, CPA
Show Raw Text
CORRESP 1 filename1.htm CORRESP October 6, 2023 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: Zevra Therapeutics, Inc. Registration Statement on Form S-4 Filed September 28, 2023 (Commission File No. 333-274758) Dear Sir or Madam: In accordance with Rule 461 under the Securities Act of 1933, as amended, Zevra Therapeutics, Inc. (the “Company”) hereby requests that the Registration Statement referred to above be declared effective on Tuesday, October 10, 2023 at 4:30 p.m. E.T. or as soon thereafter as shall be practicable. Very truly yours, /s/ R. LaDuane Clifton, CPA By: R. LaDuane Clifton, CPA Chief Financial Officer, Secretary and Treasurer cc: Robert J. Endicott Bryan Cave Leighton Paisner LLP